2G00 image
Deposition Date 2006-02-10
Release Date 2006-10-03
Last Version Date 2024-10-30
Entry Detail
PDB ID:
2G00
Keywords:
HYDROLASE
Title:
Factor Xa in complex with the inhibitor 3-(6-(2'-((dimethylamino)methyl)-4-biphenylyl)-7-oxo-3-(trifluoromethyl)-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridin-1-yl)benzamide
Biological Source:
Source Organism:
Homo sapiens (Taxon ID: 9606)
Method Details:
Experimental Method:
X-RAY DIFFRACTION
Resolution:
2.10 Å
R-Value Free:
0.28
R-Value Work:
0.26
Space Group:
P 21 21 21
2G00 validation report
Macromolecular Entities
Protein Blast
Polymer Type:polypeptide(L)
Molecule:Coagulation factor X
Gene (Uniprot):F10
Chain IDs:A
Chain Length:234
Number of Molecules:1
Biological Source:Homo sapiens
UniProt ID:P00742 Pfam ID:PF00089, PF14670 EC:3.4.21.6
Protein Blast
Polymer Type:polypeptide(L)
Molecule:Coagulation factor X
Gene (Uniprot):F10
Chain IDs:B (auth: L)
Chain Length:52
Number of Molecules:1
Biological Source:Homo sapiens
UniProt ID:P00742 Pfam ID:PF00089, PF14670 EC:3.4.21.6
Ligand Molecules
4QC
Primary Citation
Discovery of potent, efficacious, and orally bioavailable inhibitors of blood coagulation factor Xa with neutral P1 moieties.
Bioorg.Med.Chem.Lett. 16 5584 5589 (2006)
PMID: 16963264 DOI: 10.1016/j.bmcl.2006.08.027

Abstact

The bicyclic dihydropyrazolopyridinone scaffold allowed for incorporation of multiple P1 moieties with subnanomolar binding affinities for blood coagulation factor Xa. The compound 3-[6-(2'-dimethylaminomethyl-biphenyl-4-yl)-7-oxo-3-trifluoro-methyl-4,5,6,7-tetrahydro-pyrazolo[3,4-c]pyridine-l-yl]-benzamide 6d shows good fXa potency, selectivity, in vivo efficacy and oral bioavailability. Compound 6d was selected for further pre-clinical evaluations.

Legend

Protein

Chemical

Disease

Primary Citation of related structures
2G00